Quantcast

Latest Hematological malignancy Stories

2014-12-01 12:29:19

Funds Will Support Research Into Safety and Efficacy of Genetically Unmatched Cord Blood Stem Cell Transplantations Using a Myeloablative Preparative Regimen. NEW YORK, Dec.

2014-11-11 16:25:58

KB004 Phase 1/2 Clinical Data in Hematologic Malignancies to be presented at the 56th American Society of Hematology Annual Meeting and Exposition SOUTH SAN FRANCISCO, Calif., Nov.

2014-10-29 08:34:22

This Year Marks the 20th Anniversary of LLS's Prestigious Translational Research Program WHITE PLAINS, N.Y., Oct.

2014-10-28 12:31:13

The Program is Jointly Funded by LLS and Janssen Research & Development, LLC WHITE PLAINS, N.Y., Oct.

2014-10-27 04:21:55

- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - SEATTLE, Oct. 27, 2014 /PRNewswire/ -- CTI BioPharma Corp.

2014-10-09 16:27:54

Additional Global Regulatory Filings Reinforce Commitment to Addressing Significant Unmet Needs for Patients With This Aggressive Cancer With Limited Treatment Options THOUSAND OAKS,


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related